Home
Technology
Artificial Intelligence Platform
AI-enabled Site-Specific Integration Cell Line Development Platform AlfaCell
AI-enabled Cell Culture Media Development Platform AlfaMedX
AI-enabled No-screening Cell Culture Media Optimization Platform AlfaOPA
GBB Store
Druggability Assessment
Cell Line Development
Cell Culture Media Development
Detection and analysis
About GBB
About GBB
History
Board of Directors / Management Team
Company Honors
Partners
News
Company News
Video Center
Upcoming Events
Others
Join Us
中文
English
快速查找
产品服务
产品服务
产品服务
Global
Home
Technology
Artificial Intelligence Platform
AI-enabled Site-Specific Integration Cell Line Development Platform AlfaCell
AI-enabled Cell Culture Media Development Platform AlfaMedX
AI-enabled No-screening Cell Culture Media Optimization Platform AlfaOPA
GBB Store
Druggability Assessment
Cell Line Development
Cell Culture Media Development
Detection and analysis
About GBB
About GBB
History
Board of Directors / Management Team
Company Honors
Partners
News
Company News
Video Center
Upcoming Events
Others
Join Us
Global
中文
English
Another MNC! Great Bay Bio has added another overseas order
2023-10-18
香港
10月18日
继上周后,大湾生物再与一家跨国企业(MNC)签订培养基开发合作协议,再次展现大湾生物多维度参与国际无血清培养基市场开发和供应的能力。
同时,通过本次合作,该MNC将迅速推进无血清细胞培养基的新原料发现与验证,及培养基工艺的深度优化,将大幅提高生物制品研发和培养基供应效率,提升无血清细胞培养基的未来发展。
Back
Next
Prev
Related News
Great Bay Bio Listed on Forbes Asia 100 to Watch 2024
Overview of Biotechnology Development in Hong Kong
AlfaCell: Obtain High-Yield & Stable Cell Lines in 1.5 Months
AlfaDAX丨The Prediction Accuracy of Predicting Aggregation and Precipitation of 28 Innovative Molecules Reached 89.3%
Great Bay Bio Obtained Authentication of ISO 9001:2015 - Quality Management Systems
Online System for Molecule Assessment and Optimization
Uni-Bio – GBB – Pebble Accelerator Signed Agreement to Co-Develop Novel Weight-loss Drugs
Great Bay Bio’s 2024 strategy conference was successfully held
Share
Message